ArticleProceedings (Baylor University. Medical Center)2024
Denosumab versus pamidronate in the treatment of osteolytic bone metastases secondary to breast cancer: a multi-institutional analysis.
Megan Bradley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.